Addex Therapeutics boosts issued share capital to enhance financial flexibility, impacting the pharmaceutical preparations industry and its funding strategies.
| Name | Addex Therapeutics Ltd. |
|---|---|
| CIK | 0001574232 |
| Tickers | ADXN |
| Exchanges | Nasdaq |
| Entity type | other |
| Category | Non-accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | V8 Switzerland |
| Phone | 01141228841555 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Addex Therapeutics boosts issued share capital to enhance financial flexibility, impacting the pharmaceutical preparations industry and its funding strategies.
Addex Therapeutics Ltd. files a 6-K report detailing recent developments impacting its operations in the pharmaceutical preparations industry.
Addex Therapeutics has appointed Jean-Philippe Rocher as Head of Pharmaceutical Development, succeeding Mikhail Kalinichev, who steps down to focus on Neurosterix.
289 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | 4/A | OWNERSHIP DOCUMENT | 0001104659-26-128219 | 6401 | ||||||
| 2026-11-16 | 4/A | OWNERSHIP DOCUMENT | 0001104659-26-128208 | 6407 | ||||||
| 2026-11-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-127029 | 5962 | ||||||
| 2026-11-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-127027 | 5958 | ||||||
| 2026-11-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-127026 | 5956 | ||||||
| 2026-11-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-127023 | 5979 | ||||||
| 2026-11-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-127020 | 5963 | ||||||
| 2026-11-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-127014 | 5856 | ||||||
| 2026-11-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-127010 | 5960 | ||||||
| 2026-11-12 | 6-K | FORM 6-K | 0001171843-26-007354 | 001-39179 | 261542534 | 34 | 15591 | |||
| 2026-10-29 | 6-K | FORM 6-K | 0001171843-26-006946 | 001-39179 | 261497246 | 34 | 14803 | |||
| 2026-10-08 | 6-K | FORM 6-K | 0001171843-26-006524 | 001-39179 | 261448186 | 34 | 16143 | |||
| 2026-10-02 | 6-K | FORM 6-K | 0001171843-26-006345 | 001-39179 | 261433365 | 34 | 17579 | |||
| 2026-09-28 | 6-K | 6-K | 0001104659-26-111142 | 001-39179 | 261411967 | 34 | 7664676 | 1 | 1 | |
| 2026-09-25 | 6-K | FORM 6-K | 0001171843-26-006225 | 001-39179 | 261406103 | 34 | 18089 | |||
| 2026-09-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-105509 | 39185 | ||||||
| 2026-09-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-105506 | 12349 | ||||||
| 2026-09-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-105501 | 12317 | ||||||
| 2026-09-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-105496 | 12322 | ||||||
| 2026-09-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-105491 | 12211 | ||||||
| 2026-09-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-105489 | 12337 | ||||||
| 2026-09-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-105484 | 12326 | ||||||
| 2026-09-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-105481 | 12305 | ||||||
| 2026-09-04 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-105480 | 005-91805 | 261362011 | 34 | 19234 | |||
| 2026-08-27 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-101798 | 005-91805 | 261324855 | 34 | 17540 | |||
| 2026-08-26 | 6-K | FORM 6-K | 0001171843-26-005744 | 001-39179 | 261317504 | 34 | 13908 | |||
| 2026-07-08 | 6-K | FORM 6-K | 0001171843-26-004524 | 001-39179 | 261160718 | 34 | 16860 | |||
| 2026-06-30 | 6-K | FORM 6-K | 0001171843-26-004375 | 001-39179 | 261137886 | 34 | 16190 | |||
| 2026-06-25 | 6-K | FORM 6-K | 0001104659-26-077470 | 001-39179 | 261117518 | 34 | 626049 | |||
| 2026-06-05 | 6-K | FORM 6-K | 0001171843-26-003926 | 001-39179 | 261066774 | 34 | 17165 | |||
| 2026-05-15 | 20-F | FORM 20-F | 0001104659-26-062447 | 001-39179 | 26986621 | 34 | 17816115 | 1 | 1 | |
| 2026-04-30 | NT 20-F | NT 20-F | 0001104659-26-052854 | 001-39179 | 26924818 | 34 | 31181 | |||
| 2026-04-30 | 6-K | FORM 6-K | 0001171843-26-002871 | 001-39179 | 26919742 | 34 | 27570 | |||
| 2026-04-29 | 6-K | FORM 6-K | 0001171843-26-002787 | 001-39179 | 26910290 | 34 | 16586 | |||
| 2026-04-23 | 6-K | FORM 6-K | 0001171843-26-002661 | 001-39179 | 26885384 | 34 | 18334 | |||
| 2026-04-21 | 6-K | FORM 6-K | 0001171843-26-002589 | 001-39179 | 26876649 | 34 | 16910 | |||
| 2026-03-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-034503 | 13852 | ||||||
| 2026-03-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-034501 | 14214 | ||||||
| 2026-03-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-034498 | 12365 | ||||||
| 2026-03-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-034495 | 13954 | ||||||
| 2026-03-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-034491 | 13852 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030243 | 5375 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030242 | 13647 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030240 | 13894 | ||||||
| 2026-02-03 | 6-K | FORM 6-K | 0001171843-26-000580 | 001-39179 | 26590038 | 34 | 18851 | |||
| 2026-01-07 | 6-K | FORM 6-K | 0001171843-26-000110 | 001-39179 | 26513898 | 34 | 16709 | |||
| 2025-12-10 | 6-K | FORM 6-K | 0001104659-25-119971 | 001-39179 | 251561954 | 34 | 78293 | |||
| 2025-12-10 | 424B5 | 424B5 | 0001104659-25-119967 | 333-291644 | 251561913 | 33 | 1147051 | |||
| 2025-12-05 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003556 | 333-291644 | 251554498 | 33 | 1708 | ||
| 2025-12-04 | 6-K | FORM 6-K | 0001104659-25-118226 | 001-39179 | 251548168 | 34 | 1214729 | |||
| 2025-12-03 | CORRESP | filename1.htm | 0001104659-25-118120 | 8952 | ||||||
| 2025-11-19 | F-3 | F-3 | 0001104659-25-114077 | 333-291644 | 251499280 | 33 | 1204644 | 1 | 1 | |
| 2025-10-29 | 6-K | FORM 6-K | 0001171843-25-006744 | 001-39179 | 251426707 | 34 | 13656 | |||
| 2025-09-30 | 6-K | FORM 6-K | 0001104659-25-094663 | 001-39179 | 251358039 | 34 | 9614394 | 1 | 1 | |
| 2025-09-23 | 6-K | FORM 6-K | 0001171843-25-006022 | 001-39179 | 251331662 | 34 | 13190 | |||
| 2025-06-30 | 6-K | FORM 6-K | 0001171843-25-004208 | 001-39179 | 251088644 | 34 | 15489 | |||
| 2025-06-25 | 6-K | FORM 6-K | 0001171843-25-004087 | 001-39179 | 251070813 | 34 | 13486 | |||
| 2025-06-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-25-061660 | 005-91805 | 251064886 | 34 | 16817 | |||
| 2025-06-20 | 6-K | FORM 6-K | 0001104659-25-060772 | 001-39179 | 251058908 | 34 | 687559 | |||
| 2025-06-06 | 6-K | FORM 6-K | 0001171843-25-003746 | 001-39179 | 251028767 | 34 | 15291 | |||
| 2025-05-15 | 20-F | FORM 20-F | 0001104659-25-049380 | 001-39179 | 25952429 | 34 | 18750994 | 1 | 1 | |
| 2025-05-12 | 6-K | FORM 6-K | 0001171843-25-003038 | 001-39179 | 25932426 | 34 | 15045 | |||
| 2025-04-30 | NT 20-F | NT 20-F | 0001104659-25-042472 | 001-39179 | 25894728 | 34 | 33840 | |||
| 2025-04-30 | 6-K | FORM 6-K | 0001171843-25-002621 | 001-39179 | 25890655 | 34 | 15603 | |||
| 2025-04-25 | 6-K | FORM 6-K | 0001171843-25-002501 | 001-39179 | 25869784 | 34 | 1238567 | |||
| 2025-04-17 | 6-K | FORM 6-K | 0001171843-25-002264 | 001-39179 | 25844234 | 34 | 13136 | |||
| 2024-11-22 | 6-K | FORM 6-K | 0001104659-24-121730 | 001-39179 | 241486254 | 34 | 1092040 | |||
| 2024-11-12 | 6-K | FORM 6-K | 0001171843-24-006203 | 001-39179 | 241442791 | 34 | 14843 | |||
| 2024-09-30 | 6-K | FORM 6-K | 0001104659-24-103840 | 001-39179 | 241336426 | 34 | 1399665 | |||
| 2024-09-19 | 6-K | FORM 6-K | 0001171843-24-005259 | 001-39179 | 241308755 | 34 | 14652 | |||
| 2024-08-27 | 6-K | FORM 6-K | 0001171843-24-004935 | 001-39179 | 241243120 | 34 | 14613 | |||
| 2024-08-14 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#7E) | 0001072613-24-000634 | 005-91805 | 241210254 | 34 | 121531 | |||
| 2024-08-05 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#6) | 0001072613-24-000602 | 005-91805 | 241176765 | 34 | 356505 | |||
| 2024-07-22 | 6-K | FORM 6-K | 0001171843-24-004045 | 001-39179 | 241129159 | 34 | 15691 | |||
| 2024-07-15 | 6-K | FORM 6-K | 0001171843-24-003933 | 001-39179 | 241115783 | 34 | 14993 | |||
| 2024-07-01 | 6-K | FORM 6-K | 0001171843-24-003723 | 001-39179 | 241087963 | 34 | 14386 | |||
| 2024-06-06 | 6-K | FORM 6-K | 0001104659-24-068801 | 001-39179 | 241023761 | 34 | 849899 | |||
| 2024-06-05 | 6-K | FORM 6-K | 0001171843-24-003305 | 001-39179 | 241020635 | 34 | 16841 | |||
| 2024-04-29 | 6-K | FORM 6-K | 0001171843-24-002302 | 001-39179 | 24886371 | 34 | 16336 | |||
| 2024-04-24 | 424B3 | 424B3 | 0001104659-24-051210 | 333-271611 | 24870481 | 33 | 1490234 | |||
| 2024-04-22 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001104659-24-048823,2024-04-22 | 9999999995-24-001061 | 333-271611 | 24862583 | 33 | 1727 | ||
| 2024-04-18 | POS AM | POS AM | 0001104659-24-048823 | 333-271611 | 24854252 | 33 | 1615430 | |||
| 2024-04-18 | 20-F | FORM 20-F | 0001104659-24-048532 | 001-39179 | 24852737 | 34 | 15862961 | 1 | 1 | |
| 2024-04-18 | 6-K | FORM 6-K | 0001171843-24-002070 | 001-39179 | 24852720 | 34 | 23456 | |||
| 2024-04-03 | 6-K | FORM 6-K | 0001171843-24-001785 | 001-39179 | 24816770 | 34 | 19310 | |||
| 2024-01-30 | 424B5 | 424B5 | 0001104659-24-008319 | 333-255089 | 24579010 | 33 | 1201688 | |||
| 2024-01-30 | 6-K | FORM 6-K | 0001104659-24-008318 | 001-39179 | 24578973 | 34 | 275424 | |||
| 2023-12-21 | 6-K/A | FORM 6-K/A | 0001104659-23-127862 | 001-39179 | 231502714 | 34 | 6637101 | 1 | 1 | |
| 2023-12-20 | 6-K | FORM 6-K | 0001171843-23-007632 | 001-39179 | 231499329 | 34 | 13134 | |||
| 2023-12-14 | 6-K | FORM 6-K | 0001171843-23-007563 | 001-39179 | 231485497 | 34 | 13627 | |||
| 2023-12-08 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#5) | 0001072613-23-000611 | 005-91805 | 231474978 | 34 | 311315 | |||
| 2023-11-30 | 424B3 | 424B3 | 0001104659-23-122406 | 333-271611 | 231455665 | 33 | 496626 | |||
| 2023-11-29 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001104659-23-121793,2023-11-29 | 9999999995-23-003479 | 333-271611 | 231453846 | 33 | 1679 | ||
| 2023-11-29 | SC 13D/A | SC 13D/A | 0001104659-23-122019 | 005-91805 | 231452091 | 34 | 58389 | |||
| 2023-11-29 | POS AM | POS AM | 0001104659-23-121793 | 333-271611 | 231448389 | 33 | 612152 | |||
| 2023-11-29 | 6-K | FORM 6-K | 0001104659-23-121737 | 001-39179 | 231448284 | 34 | 1225103 | |||
| 2023-11-28 | 6-K | FORM 6-K | 0001171843-23-007294 | 001-39179 | 231441787 | 34 | 13281 | |||
| 2023-11-14 | 6-K | FORM 6-K | 0001171843-23-007060 | 001-39179 | 231401332 | 34 | 17070 | |||
| 2023-11-08 | 6-K | FORM 6-K | 0001171843-23-006845 | 001-39179 | 231385801 | 34 | 13360 | |||
| 2023-10-23 | 424B3 | 424B3 | 0001104659-23-110607 | 333-271611 | 231338417 | 33 | 500252 | |||
| 2023-10-20 | 6-K | FORM 6-K | 0001171843-23-006324 | 001-39179 | 231335908 | 34 | 14661 | |||
| 2023-10-06 | F-6 POS | e618986_f6pos-addex.htm | 0001193805-23-001379 | 333-235561 | 231314513 | 33 | 673830 | |||
| 2023-10-06 | 6-K | FORM 6-K | 0001171843-23-006132 | 001-39179 | 231314191 | 34 | 15354 | |||
| 2023-09-20 | 6-K | FORM 6-K | 0001171843-23-005796 | 001-39179 | 231265229 | 34 | 17040 | |||
| 2023-09-05 | 6-K | FORM 6-K | 0001171843-23-005543 | 001-39179 | 231234048 | 34 | 17153 | |||
| 2023-09-05 | 6-K | FORM 6-K | 0001171843-23-005540 | 001-39179 | 231234045 | 34 | 16209 | |||
| 2023-08-11 | 424B3 | 424B3 | 0001104659-23-090450 | 333-271611 | 231163854 | 33 | 1324115 | |||
| 2023-08-10 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001104659-23-089769,2023-08-10 | 9999999995-23-002338 | 333-271611 | 231161367 | 33 | 1679 | ||
| 2023-08-10 | POS AM | POS AM | 0001104659-23-089769 | 333-271611 | 231159114 | 33 | 1621882 | |||
| 2023-08-10 | 6-K | FORM 6-K | 0001104659-23-089501 | 001-39179 | 231157090 | 34 | 1080761 | |||
| 2023-08-03 | 6-K | FORM 6-K | 0001171843-23-004937 | 001-39179 | 231137858 | 34 | 14943 | |||
| 2023-07-24 | 6-K | FORM 6-K | 0001171843-23-004600 | 001-39179 | 231103655 | 34 | 16949 | |||
| 2023-06-15 | 6-K | FORM 6-K | 0001171843-23-003938 | 001-39179 | 231015889 | 34 | 13695 | |||
| 2023-06-08 | S-8 | FORM S-8 | 0001104659-23-069380 | 333-272515 | 231001922 | 33 | 132138 | |||
| 2023-06-02 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2023-06-02 16:00:00 | 9999999995-23-001619 | 333-271611 | 23991113 | 33 | 1665 | ||
| 2023-06-02 | 424B3 | 424B3 | 0001104659-23-067594 | 333-271611 | 23989410 | 33 | 549383 | |||
| 2023-06-01 | CORRESP | filename1.htm | 0001104659-23-067025 | 7567 | ||||||
| 2023-06-01 | F-1/A | FORM F-1/A | 0001104659-23-067020 | 333-271611 | 23984616 | 33 | 801808 | |||
| 2023-06-01 | 6-K | FORM 6-K | 0001171843-23-003680 | 001-39179 | 23982929 | 34 | 14930 | |||
| 2023-05-18 | 6-K | FORM 6-K | 0001171843-23-003402 | 001-39179 | 23933637 | 34 | 14002 | |||
| 2023-05-12 | CORRESP | filename1.htm | 0001104659-23-059720 | 7437 | ||||||
| 2023-05-11 | CORRESP | filename1.htm | 0001104659-23-059144 | 7114 | ||||||
| 2023-05-11 | F-1/A | F-1/A | 0001104659-23-059096 | 333-271611 | 23910790 | 33 | 644178 | |||
| 2023-05-11 | 6-K | FORM 6-K | 0001104659-23-058681 | 001-39179 | 23908621 | 34 | 670883 | |||
| 2023-05-10 | 6-K | FORM 6-K | 0001171843-23-003121 | 001-39179 | 23904168 | 34 | 16973 | |||
| 2023-05-09 | UPLOAD | filename1.pdf | 0000000000-23-004854 | 40164 | ||||||
| 2023-05-05 | 6-K | FORM 6-K | 0001171843-23-002923 | 001-39179 | 23891067 | 34 | 14647 | |||
| 2023-05-03 | F-1 | F-1 | 0001104659-23-055487 | 333-271611 | 23883681 | 33 | 712633 | |||
| 2023-04-13 | D | xslFormDX01/primary_doc.xml | 06b | 0001231919-23-000017 | 021-478677 | 23817114 | 33 | 12858 | ||
| 2023-04-10 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#4) | 0001072613-23-000298 | 005-91805 | 23811204 | 34 | 335934 | |||
| 2023-04-05 | SC 13D/A | SC 13D/A | 0001104659-23-042133 | 005-91805 | 23802393 | 34 | 54153 | |||
| 2023-04-04 | 424B5 | 424B5 | 0001104659-23-041624 | 333-255089 | 23799450 | 33 | 1625270 | |||
| 2023-04-04 | 6-K | FORM 6-K | 0001104659-23-041530 | 001-39179 | 23798070 | 34 | 721099 | |||
| 2023-04-04 | 6-K | FORM 6-K | 0001171843-23-002102 | 001-39179 | 23795017 | 34 | 15856 | |||
| 2023-04-03 | 6-K | FORM 6-K | 0001171843-23-002052 | 001-39179 | 23790287 | 34 | 16706 | |||
| 2023-03-31 | SC 13D/A | SC 13D/A | 0001104659-23-040143 | 005-91805 | 23787334 | 34 | 51476 | |||
| 2023-03-30 | 6-K | FORM 6-K | 0001171843-23-001991 | 001-39179 | 23777028 | 34 | 23179 | |||
| 2023-03-30 | 20-F | FORM 20-F | 0001104659-23-038581 | 001-39179 | 23777022 | 34 | 15521429 | 1 | 1 | |
| 2023-02-16 | SC 13G/A | armistice-adxn123122a2.htm | 0001172661-23-001496 | 005-91805 | 23638121 | 34 | 91740 | |||
| 2023-02-14 | SC 13G/A | d9939896_13g-a.htm | 0000919574-23-001480 | 005-91805 | 23625600 | 34 | 124387 | |||
| 2023-02-14 | SC 13G/A | armistice-adxn123122a1.htm | 0001172661-23-001034 | 005-91805 | 23625073 | 34 | 90871 | |||
| 2023-02-09 | 6-K | FORM 6-K | 0001171843-23-000819 | 001-39179 | 23600964 | 34 | 13859 | |||
| 2023-02-08 | SC 13G/A | ADDEX_THERAPEUTICS.txt | 0000769993-23-000098 | 005-91805 | 23596427 | 34 | 23685 | |||
| 2023-02-06 | SC 13G/A | SC 13G/A | 0001193125-23-025648 | 005-91805 | 23591125 | 34 | 98439 | |||
| 2023-02-06 | 6-K | FORM 6-K | 0001171843-23-000693 | 001-39179 | 23588254 | 34 | 17311 | |||
| 2023-01-19 | 6-K | FORM 6-K | 0001171843-23-000320 | 001-39179 | 23535857 | 34 | 16339 | |||
| 2022-12-08 | 6-K | FORM 6-K | 0001171843-22-007896 | 001-39179 | 221451347 | 34 | 16594 | |||
| 2022-11-28 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A3 | 0001072613-22-000649 | 005-91805 | 221424906 | 34 | 335426 | |||
| 2022-11-23 | SC 13D/A | SC 13D/A | 0001104659-22-121418 | 005-91805 | 221412175 | 34 | 56791 | |||
| 2022-11-22 | 424B3 | 424B3 | 0001104659-22-120912 | 333-262050 | 221407372 | 33 | 1123050 | |||
| 2022-11-16 | 424B3 | 424B3 | 0001104659-22-119360 | 333-266995 | 221393046 | 33 | 960419 | |||
| 2022-11-14 | 6-K | FORM 6-K | 0001104659-22-117358 | 001-39179 | 221379483 | 34 | 986464 | |||
| 2022-11-09 | SC 13D/A | SC 13D/A | 0001104659-22-116458 | 005-91805 | 221372410 | 34 | 52319 | |||
| 2022-11-03 | 6-K | FORM 6-K | 0001171843-22-007037 | 001-39179 | 221355979 | 34 | 14633 | |||
| 2022-11-01 | 6-K | FORM 6-K | 0001171843-22-006933 | 001-39179 | 221348357 | 34 | 28130 | |||
| 2022-09-14 | 6-K/A | FORM 6-K/A | 0001104659-22-099810 | 001-39179 | 221242014 | 34 | 7064485 | 1 | 1 | |
| 2022-08-30 | 424B3 | 424B3 | 0001104659-22-096021 | 333-266995 | 221214551 | 33 | 1107938 | |||
| 2022-08-29 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001104659-22-094025,2022-08-29 | 9999999995-22-002531 | 333-262050 | 221212817 | 33 | 1679 | ||
| 2022-08-29 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2022-08-29 16:00:00 | 9999999995-22-002544 | 333-266995 | 221212810 | 33 | 1666 | ||
| 2022-08-25 | CORRESP | filename1.htm | 0001104659-22-094419 | 8468 | ||||||
| 2022-08-25 | UPLOAD | filename1.pdf | 0000000000-22-009203 | 40126 | ||||||
| 2022-08-24 | POS AM | POS AM | 0001104659-22-094025 | 333-262050 | 221191581 | 33 | 1248138 | |||
| 2022-08-23 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A2 | 0001072613-22-000523 | 005-91805 | 221188313 | 34 | 337166 | |||
| 2022-08-19 | F-1 | F-1 | 0001104659-22-093004 | 333-266995 | 221181437 | 33 | 1485502 | |||
| 2022-08-18 | 6-K | FORM 6-K | 0001104659-22-092309 | 001-39179 | 221176269 | 34 | 986803 | |||
| 2022-08-15 | 6-K | FORM 6-K | 0001171843-22-005651 | 001-39179 | 221162091 | 34 | 19546 | |||
| 2022-08-05 | SC 13D/A | SC 13D/A | 0001104659-22-086368 | 005-91805 | 221138442 | 34 | 54443 | |||
| 2022-08-04 | D | xslFormDX01/primary_doc.xml | 06b | 0001231919-22-000052 | 021-454872 | 221135631 | 33 | 13716 | ||
| 2022-07-26 | 6-K | FORM 6-K | 0001104659-22-082772 | 001-39179 | 221107185 | 34 | 541933 | |||
| 2022-07-26 | 424B5 | 424B5 | 0001104659-22-082766 | 333-255089 | 221107118 | 33 | 2124302 | |||
| 2022-07-22 | 6-K | FORM 6-K | 0001171843-22-004952 | 001-39179 | 221098373 | 34 | 16136 | |||
| 2022-07-21 | 6-K | FORM 6-K | 0001171843-22-004927 | 001-39179 | 221095492 | 34 | 16351 | |||
| 2022-07-21 | 6-K | FORM 6-K | 0001171843-22-004926 | 001-39179 | 221095493 | 34 | 13941 | |||
| 2022-07-20 | 424B5 | 424B5 | 0001104659-22-080927 | 333-262050 | 221092592 | 33 | 1163587 | |||
| 2022-06-17 | 6-K | FORM 6-K | 0001171843-22-004400 | 001-39179 | 221022341 | 34 | 14622 | |||
| 2022-05-27 | 6-K | FORM 6-K | 0001171843-22-003993 | 001-39179 | 22972468 | 34 | 17229 | |||
| 2022-05-10 | 6-K | FORM 6-K | 0001171843-22-003474 | 001-39179 | 22907206 | 34 | 16209 | |||
| 2022-05-05 | 6-K | FORM 6-K | 0001104659-22-056038 | 001-39179 | 22893816 | 34 | 717837 | |||
| 2022-04-19 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001104659-22-039084,2022-04-19 | 9999999995-22-001013 | 333-235554 | 22836238 | 33 | 1678 | ||
| 2022-04-13 | 6-K | FORM 6-K | 0001171843-22-002560 | 001-39179 | 22823567 | 34 | 16437 | |||
| 2022-04-06 | 6-K | FORM 6-K | 0001171843-22-002409 | 001-39179 | 22809309 | 34 | 15074 | |||
| 2022-04-04 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001104659-22-041024,2022-04-04 | 9999999995-22-000815 | 333-262050 | 22805085 | 33 | 1678 | ||
| 2022-03-31 | POS AM | POS AM | 0001104659-22-041024 | 333-262050 | 22792562 | 33 | 1401727 | |||
| 2022-03-31 | 6-K | FORM 6-K | 0001171843-22-002201 | 001-39179 | 22788983 | 34 | 15914 | |||
| 2022-03-29 | CORRESP | filename1.htm | 0001104659-22-039088 | 23405 | ||||||
| 2022-03-29 | POS AM | POS AM | 0001104659-22-039084 | 333-235554 | 22777364 | 33 | 50285 | |||
| 2022-03-10 | 6-K | FORM 6-K | 0001171843-22-001750 | 001-39179 | 22727297 | 34 | 25176 | |||
| 2022-03-10 | 20-F | 20-F | 0001104659-22-032171 | 001-39179 | 22727281 | 34 | 13563967 | 1 | 1 | |
| 2022-02-18 | SC 13G/A | SC 13G/A - AMENDMENT NO. 2 | 0001193125-22-046701 | 005-91805 | 22653596 | 34 | 98940 | |||
| 2022-02-15 | SC 13G | SC 13G | 0001193125-22-042412 | 005-91805 | 22635946 | 34 | 69486 | |||
| 2022-02-14 | SC 13G/A | d9177801_13g-a.htm | 0000919574-22-001580 | 005-91805 | 22631661 | 34 | 125410 | |||
| 2022-02-14 | SC 13G | ADDEX THERAPEUTICS | 0000769993-22-000232 | 005-91805 | 22630594 | 34 | 23457 | |||
| 2022-02-14 | SC 13G/A | NONE | 0001567619-22-004128 | 005-91805 | 22629196 | 34 | 69392 | |||
| 2022-02-11 | SC 13G/A | SC 13G/A | 0001193125-22-037244 | 005-91805 | 22622062 | 34 | 98623 | |||
| 2022-02-03 | 6-K | FORM 6-K | 0001171843-22-000721 | 001-39179 | 22586371 | 34 | 14915 | |||
| 2022-01-19 | 424B3 | 424B3 | 0001104659-22-004979 | 333-262050 | 22536124 | 33 | 1178663 | |||
| 2022-01-18 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2022-01-18 16:00:00 | 9999999995-22-000163 | 333-262050 | 22536708 | 33 | 1665 | ||
| 2022-01-14 | CORRESP | filename1.htm | 0001104659-22-004409 | 7620 | ||||||
| 2022-01-14 | UPLOAD | filename1.pdf | 0000000000-22-000500 | 40124 | ||||||
| 2022-01-10 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13DA1 | 0001072613-22-000026 | 005-91805 | 22520688 | 34 | 335814 | |||
| 2022-01-07 | F-1 | F-1 | 0001104659-22-002264 | 333-262050 | 22518262 | 33 | 1315446 | |||
| 2021-12-21 | D | xslFormDX01/primary_doc.xml | 06b | 0001231919-21-000092 | 021-426200 | 211510011 | 33 | 13789 | ||
| 2021-12-20 | 424B5 | 424B5 | 0001104659-21-151327 | 333-255089 | 211503357 | 33 | 1859155 | |||
| 2021-12-20 | 6-K | FORM 6-K | 0001104659-21-151325 | 001-39179 | 211503348 | 34 | 669464 | |||
| 2021-12-15 | 6-K | FORM 6-K | 0001104659-21-149825 | 001-39179 | 211493324 | 34 | 105438 | |||
| 2021-11-15 | 6-K | FORM 6-K | 0001171843-21-007893 | 001-39179 | 211406014 | 34 | 14712 | |||
| 2021-11-04 | 6-K | FORM 6-K | 0001104659-21-134002 | 001-39179 | 211377908 | 34 | 963432 | |||
| 2021-09-29 | 6-K | FORM 6-K | 0001171843-21-006692 | 001-39179 | 211289122 | 34 | 14426 | |||
| 2021-09-22 | 6-K | FORM 6-K | 0001171843-21-006588 | 001-39179 | 211268097 | 34 | 15829 | |||
| 2021-09-08 | SC 13D/A | SC 13D/A | 0001104659-21-113568 | 005-91805 | 211240588 | 34 | 61594 | |||
| 2021-08-05 | 6-K | FORM 6-K | 0001104659-21-100324 | 001-39179 | 211146058 | 34 | 913110 | |||
| 2021-08-02 | 6-K | FORM 6-K | 0001171843-21-005337 | 001-39179 | 211134515 | 34 | 13584 | |||
| 2021-07-29 | 6-K | FORM 6-K | 0001171843-21-005231 | 001-39179 | 211124653 | 34 | 15074 | |||
| 2021-07-01 | 6-K | FORM 6-K | 0001171843-21-004633 | 001-39179 | 211063916 | 34 | 15756 | |||
| 2021-06-30 | 6-K | FORM 6-K | 0001104659-21-087037 | 001-39179 | 211060014 | 34 | 306844 | |||
| 2021-06-30 | 424B5 | 424B5 | 0001047469-21-001224 | 333-255089 | 211060007 | 33 | 1293806 | |||
| 2021-06-29 | 6-K | FORM 6-K | 0001171843-21-004572 | 001-39179 | 211055464 | 34 | 16014 | |||
| 2021-06-17 | 6-K | FORM 6-K | 0001171843-21-004385 | 001-39179 | 211023301 | 34 | 13836 | |||
| 2021-06-07 | 6-K | FORM 6-K | 0001171843-21-004139 | 001-39179 | 21998128 | 34 | 14872 | |||
| 2021-05-17 | 6-K | FORM 6-K | 0001171843-21-003552 | 001-39179 | 21927274 | 34 | 15214 | |||
| 2021-05-14 | 6-K | FORM 6-K | 0001171843-21-003514 | 001-39179 | 21921793 | 34 | 16048 | |||
| 2021-05-05 | 6-K | FORM 6-K | 0001104659-21-061314 | 001-39179 | 21891000 | 34 | 640251 | |||
| 2021-04-26 | 6-K | FORM 6-K | 0001171843-21-002733 | 001-39179 | 21851430 | 34 | 12698 | |||
| 2021-04-13 | EFFECT | xslEFFECTX01/primary_doc.xml | F-3,,2021-04-13 16:00:00 | 9999999995-21-001414 | 333-255089 | 21824437 | 33 | 1608 | ||
| 2021-04-12 | CORRESP | filename1.htm | 0001104659-21-049123 | 9368 | ||||||
| 2021-04-09 | UPLOAD | filename1.pdf | 0000000000-21-004321 | 40030 | ||||||
| 2021-04-08 | S-8 | S-8 | 0001104659-21-048040 | 333-255124 | 21814950 | 33 | 386674 | |||
| 2021-04-08 | 6-K | FORM 6-K | 0001171843-21-002376 | 001-39179 | 21813698 | 34 | 12476 | |||
| 2021-04-07 | F-3 | F-3 | 0001047469-21-000882 | 333-255089 | 21812182 | 33 | 772344 | |||
| 2021-03-11 | 6-K | FORM 6-K | 0001171843-21-001671 | 001-39179 | 21731764 | 34 | 23585 | |||
| 2021-03-11 | 20-F | 20-F | 0001047469-21-000566 | 001-39179 | 21731748 | 34 | 12781757 | 1 | ||
| 2021-02-17 | 6-K | FORM 6-K | 0001171843-21-001074 | 001-39179 | 21642540 | 34 | 13691 | |||
| 2021-02-16 | SC 13G | d8798330_13g.htm | 0000919574-21-001601 | 005-91805 | 21638828 | 34 | 137361 | |||
| 2021-02-16 | 6-K | FORM 6-K | 0001171843-21-001031 | 001-39179 | 21631767 | 34 | 15556 | |||
| 2021-02-12 | SC 13G | NONE | 0001567619-21-003449 | 005-91805 | 21626808 | 34 | 69376 | |||
| 2021-02-10 | SC 13G | SC 13G | 0001193125-21-036512 | 005-91805 | 21615276 | 34 | 116125 | |||
| 2021-02-01 | UPLOAD | filename1.pdf | 0000000000-21-001230 | 42025 | ||||||
| 2021-01-22 | SC 13D | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D | 0001072613-21-000050 | 005-91805 | 21543235 | 34 | 380041 | |||
| 2021-01-21 | 6-K | FORM 6-K | 0001171843-21-000352 | 001-39179 | 21540300 | 34 | 14192 | |||
| 2021-01-12 | 6-K | FORM 6-K | 0001171843-21-000213 | 001-39179 | 21522428 | 34 | 14985 | |||
| 2021-01-08 | 424B4 | 424B4 | 0001047469-21-000043 | 333-251322 | 21518372 | 33 | 4528013 | |||
| 2021-01-07 | 6-K | FORM 6-K | 0001171843-21-000150 | 001-39179 | 21512796 | 34 | 14364 | |||
| 2021-01-06 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2021-01-06 17:15:00 | 9999999995-21-000043 | 333-251322 | 21512894 | 33 | 1608 | ||
| 2021-01-06 | CORRESP | filename1.htm | 0001104659-21-001205 | 16886 | ||||||
| 2021-01-06 | F-1/A | F-1/A | 0001047469-21-000017 | 333-251322 | 21508799 | 33 | 4978027 | |||
| 2021-01-05 | CORRESP | filename1.htm | 0001104659-21-001198 | 12790 | ||||||
| 2020-12-14 | DEL AM | DEL AM | 0001104659-20-135270 | 333-251322 | 201386492 | 33 | 13176 | |||
| 2020-12-14 | 6-K | FORM 6-K | 0001171843-20-008532 | 001-39179 | 201385607 | 34 | 12950 | |||
| 2020-12-14 | F-1 | F-1 | 0001047469-20-005701 | 333-251322 | 201385534 | 33 | 4834118 | |||
| 2020-11-03 | SC 13D | SC 13D | 0001104659-20-120940 | 005-91805 | 201283593 | 34 | 55531 | |||
| 2020-11-03 | 6-K | FORM 6-K | 0001104659-20-120682 | 001-39179 | 201281815 | 34 | 875082 | |||
| 2020-11-02 | 6-K | FORM 6-K | 0001171843-20-007448 | 001-39179 | 201278864 | 34 | 15571 | |||
| 2020-10-15 | UPLOAD | filename1.pdf | 0000000000-20-009766 | 40365 | ||||||
| 2020-10-13 | DRS | filename1.htm | 0001410578-20-000137 | 377-03653 | 201235017 | 33 | 4485921 | |||
| 2020-08-27 | 6-K | FORM 6-K | 0001171843-20-006121 | 001-39179 | 201138954 | 34 | 15013 | |||
| 2020-08-12 | 6-K | 6-K | 0001104659-20-093460 | 001-39179 | 201093977 | 34 | 1234129 | |||
| 2020-07-20 | 6-K | FORM 6-K | 0001171843-20-005029 | 001-39179 | 201034933 | 34 | 12544 | |||
| 2020-06-16 | 6-K | FORM 6-K | 0001171843-20-004382 | 001-39179 | 20964915 | 34 | 14039 | |||
| 2020-06-10 | 6-K | FORM 6-K | 0001171843-20-004265 | 001-39179 | 20953446 | 34 | 13331 | |||
| 2020-05-20 | 6-K | 6-K | 0001104659-20-063978 | 001-39179 | 20895663 | 34 | 829890 | |||
| 2020-05-19 | 6-K | FORM 6-K | 0001171843-20-003822 | 001-39179 | 20891531 | 34 | 14937 | |||
| 2020-05-11 | UPLOAD | filename1.pdf | 0000000000-20-004127 | 42653 | ||||||
| 2020-04-27 | POS AM | POS AM | 0001047469-20-002582 | 333-235554 | 20816986 | 33 | 3320083 | |||
| 2020-04-27 | 20-F | 20-F | 0001047469-20-002580 | 001-39179 | 20816974 | 34 | 12203526 | 1 | ||
| 2020-04-08 | 6-K | FORM 6-K | 0001171843-20-002470 | 001-39179 | 20781043 | 34 | 24249 | |||
| 2020-03-18 | 6-K | 6-K | 0001104659-20-035090 | 001-39179 | 20723728 | 34 | 33076 | |||
| 2020-03-06 | 6-K | 6-K | 0001104659-20-030079 | 001-39179 | 20693829 | 34 | 34062 | |||
| 2020-01-28 | 424B4 | 424B4 | 0001047469-20-000551 | 333-235554 | 20555642 | 33 | 3732849 | |||
| 2020-01-28 | CERT | 8A_Cert_ADXN.pdf | 0001354457-20-000035 | 001-39179 | 20554368 | 34 | 205545 | |||
| 2020-01-27 | EFFECT | xslEFFECTX01/primary_doc.xml | F-6,,2020-01-27 16:00:00 | 9999999995-20-000167 | 333-235561 | 20551234 | 33 | 1692 | ||
| 2020-01-27 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2020-01-27 16:00:00 | 9999999995-20-000166 | 333-235554 | 20551233 | 33 | 1692 | ||
| 2020-01-23 | CORRESP | filename1.htm | 0001104659-20-006230 | 10950 | ||||||
| 2020-01-23 | CORRESP | filename1.htm | 0001104659-20-006229 | 20614 | ||||||
| 2020-01-23 | F-1/A | F-1/A | 0001047469-20-000443 | 333-235554 | 20541468 | 33 | 3786629 | |||
| 2020-01-15 | UPLOAD | filename1.pdf | 0000000000-20-000377 | 48158 | ||||||
| 2020-01-14 | 8-A12B | 8-A12B | 0001104659-20-003571 | 001-39179 | 20524885 | 34 | 24457 | |||
| 2020-01-14 | F-1/A | F-1A | 0001047469-20-000221 | 333-235554 | 20524876 | 33 | 4028283 | |||
| 2020-01-13 | CORRESP | filename1.htm | 0001104659-20-003569 | 15071 | ||||||
| 2019-12-31 | UPLOAD | filename1.pdf | 0000000000-19-016886 | 42922 | ||||||
| 2019-12-18 | F-6 | e619246_f6-addex.htm | 0001193805-19-001947 | 333-235561 | 191291683 | 33 | 528758 | |||
| 2019-12-17 | CORRESP | filename1.htm | 0001104659-19-073483 | 27453 | ||||||
| 2019-12-17 | F-1 | F-1 | 0001047469-19-006857 | 333-235554 | 191290551 | 33 | 6103395 | |||
| 2019-12-16 | SEC STAFF LETTER | filename1.pdf | 9999999997-19-007882 | 226614 | ||||||
| 2019-12-12 | UPLOAD | filename1.pdf | 0000000000-19-016316 | 48525 | ||||||
| 2019-11-27 | DRSLTR | filename1.htm | 0000912057-19-000443 | 55005 | ||||||
| 2019-11-27 | DRS/A | filename1.htm | 0000912057-19-000442 | 377-02847 | 191253186 | 33 | 4917335 | |||
| 2019-10-24 | UPLOAD | filename1.pdf | 0000000000-19-014823 | 59246 | ||||||
| 2019-09-26 | SEC STAFF LETTER | filename1.pdf | 9999999997-19-007125 | 147502 | ||||||
| 2019-09-24 | DRS | filename1.htm | 0000912057-19-000390 | 377-02847 | 191109070 | 33 | 5278511 |
One latest value per concept from companyfacts (196 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 147.83M | 2025-12-31 | 2025 | FY | 20-F | 2026-05-15 | 0001104659-26-062447 | |
| ifrs-full | AccrualsClassifiedAsCurrent | AccrualsClassifiedAsCurrent | CHF | 420,368 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | ActuarialAssumptionOfDiscountRates | ActuarialAssumptionOfDiscountRates | pure | 0.01 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | ActuarialAssumptionOfExpectedRatesOfPensionIncreases | ActuarialAssumptionOfExpectedRatesOfPensionIncreases | pure | 0 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | ActuarialAssumptionOfExpectedRatesOfSalaryIncreases | ActuarialAssumptionOfExpectedRatesOfSalaryIncreases | pure | 0.01 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill | AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill | CHF | 182,348 | 2024-01-01 | 2024-12-31 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment | AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment | CHF | 1,273 | 2024-01-01 | 2024-12-31 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdditionsToRightofuseAssets | AdditionsToRightofuseAssets | CHF | 2,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 20-F | 2023-03-30 | 0001104659-23-038581 |
| ifrs-full | AdjustedWeightedAverageShares | AdjustedWeightedAverageShares | shares | 99.44M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInContractAssets | AdjustmentsForDecreaseIncreaseInContractAssets | CHF | 10,387 | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInOtherFinancialAssets | AdjustmentsForDecreaseIncreaseInOtherFinancialAssets | CHF | -498 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInPrepaidExpenses | AdjustmentsForDecreaseIncreaseInPrepaidExpenses | CHF | -81,430 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables | AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables | CHF | -22,926 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdjustmentsForDepreciationExpense | AdjustmentsForDepreciationExpense | CHF | 4,236 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdjustmentsForFinanceCosts | AdjustmentsForFinanceCosts | CHF | 686,886 | 2020-01-01 | 2020-12-31 | 2020 | FY | 20-F | 2021-03-11 | 0001047469-21-000566 |
| ifrs-full | AdjustmentsForFinanceIncomeCost | AdjustmentsForFinanceIncomeCost | CHF | -33,399 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInContractLiabilities | AdjustmentsForIncreaseDecreaseInContractLiabilities | CHF | -733,668 | 2021-01-01 | 2021-12-31 | 2023 | FY | 20-F | 2024-04-18 | 0001104659-24-048532 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInDeferredIncome | AdjustmentsForIncreaseDecreaseInDeferredIncome | CHF | -244,298 | 2020-01-01 | 2020-12-31 | 2020 | FY | 20-F | 2021-03-11 | 0001047469-21-000566 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities | AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities | CHF | -38,401 | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables | AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables | CHF | 347,082 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets | AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets | CHF | -127 | 2021-01-01 | 2021-12-31 | 2022 | FY | 20-F | 2023-03-30 | 0001104659-23-038581 |
| ifrs-full | AdjustmentsForProvisions | AdjustmentsForProvisions | CHF | 2,003 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdjustmentsForSharebasedPayments | AdjustmentsForSharebasedPayments | CHF | 44,098 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AdjustmentsForUndistributedProfitsOfAssociates | AdjustmentsForUndistributedProfitsOfAssociates | CHF | -2.08M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | AmortisationIntangibleAssetsOtherThanGoodwill | AmortisationIntangibleAssetsOtherThanGoodwill | CHF | 182,348 | 2024-01-01 | 2024-12-31 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ApplicableTaxRate | ApplicableTaxRate | pure | 0.14 | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-04-18 | 0001104659-24-048532 |
| ifrs-full | AssetbackedSecuritiesPercentageContributedToFairValueOfPlanAssets | AssetbackedSecuritiesPercentageContributedToFairValueOfPlanAssets | pure | 0.123 | 2023-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | Assets | Assets | CHF | 8.51M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | AverageNumberOfEmployees | AverageNumberOfEmployees | employee | 25 | 2021-01-01 | 2021-12-31 | 2022 | FY | 20-F | 2023-03-30 | 0001104659-23-038581 |
| ifrs-full | BasicAndDilutedEarningsLossPerShare | BasicAndDilutedEarningsLossPerShare | CHF | -0.48 | 2020-01-01 | 2020-12-31 | 2020 | FY | 20-F | 2021-03-11 | 0001047469-21-000566 |
| ifrs-full | BasicEarningsLossPerShare | BasicEarningsLossPerShare | CHF/shares | -0.03 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | BasicEarningsLossPerShareFromContinuingOperations | BasicEarningsLossPerShareFromContinuingOperations | CHF/shares | -0.03 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | BasicEarningsLossPerShareFromDiscontinuedOperations | BasicEarningsLossPerShareFromDiscontinuedOperations | CHF/shares | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | Cash | Cash | CHF | 2.30M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | CashAndCashEquivalents | CashAndCashEquivalents | CHF | 2.30M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | CashAndCashEquivalentsPercentageContributedToFairValueOfPlanAssets | CashAndCashEquivalentsPercentageContributedToFairValueOfPlanAssets | pure | 0.004 | 2023-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | CashFlowsFromUsedInFinancingActivities | CashFlowsFromUsedInFinancingActivities | CHF | 747,185 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | CashFlowsFromUsedInInvestingActivities | CashFlowsFromUsedInInvestingActivities | CHF | -737,356 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | CashFlowsFromUsedInOperatingActivities | CashFlowsFromUsedInOperatingActivities | CHF | -1.02M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | CashOnHand | CashOnHand | CHF | 115 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | CashOutflowForLeases | CashOutflowForLeases | CHF | 100,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 |
| ifrs-full | ComprehensiveIncome | ComprehensiveIncome | CHF | -3.26M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ComprehensiveIncomeFromContinuingOperations | ComprehensiveIncomeFromContinuingOperations | CHF | -3.38M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ComprehensiveIncomeFromDiscontinuedOperations | ComprehensiveIncomeFromDiscontinuedOperations | CHF | 117,747 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ContractAssets | ContractAssets | CHF | 40,907 | 2023-12-31 | 2023 | FY | 20-F | 2024-04-18 | 0001104659-24-048532 | |
| ifrs-full | ContractualCapitalCommitments | ContractualCapitalCommitments | CHF | 0 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | CurrentAssets | CurrentAssets | CHF | 2.66M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings | CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings | CHF | 0 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | CurrentContractAssets | CurrentContractAssets | CHF | 40,907 | 2023-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | CurrentContractLiabilities | CurrentContractLiabilities | CHF | 733,668 | 2020-12-31 | 2021 | FY | 20-F | 2022-03-10 | 0001104659-22-032171 | |
| ifrs-full | CurrentDeferredIncomeOtherThanCurrentContractLiabilities | CurrentDeferredIncomeOtherThanCurrentContractLiabilities | CHF | 234,978 | 2023-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | CurrentLeaseLiabilities | CurrentLeaseLiabilities | CHF | 7,491 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | CurrentLiabilities | CurrentLiabilities | CHF | 1.15M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax | CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax | CHF | 82,500 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | CurrentPrepaidExpenses | CurrentPrepaidExpenses | CHF | 162,839 | 2020-12-31 | 2021 | FY | 20-F | 2022-03-10 | 0001104659-22-032171 | |
| ifrs-full | CurrentPrepayments | CurrentPrepayments | CHF | 251,079 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | CurrentServiceCostDefinedBenefitPlans | CurrentServiceCostDefinedBenefitPlans | CHF | 15,043 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | DebtInstrumentsPercentageContributedToFairValueOfPlanAssets | DebtInstrumentsPercentageContributedToFairValueOfPlanAssets | pure | 0.464 | 2023-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | DeferredIncome | DeferredIncome | CHF | 86,481 | 2020-12-31 | 2020 | FY | 20-F | 2021-03-11 | 0001047469-21-000566 | |
| ifrs-full | DeferredIncomeClassifiedAsCurrent | DeferredIncomeClassifiedAsCurrent | CHF | 86,481 | 2020-12-31 | 2020 | FY | 20-F | 2021-03-11 | 0001047469-21-000566 | |
| ifrs-full | DeferredIncomeClassifiedAsNoncurrent | DeferredIncomeClassifiedAsNoncurrent | CHF | 165,390 | 2019-12-31 | 2020 | FY | 20-F | 2021-03-11 | 0001047469-21-000566 | |
| ifrs-full | DeferredIncomeOtherThanContractLiabilities | DeferredIncomeOtherThanContractLiabilities | CHF | 324,210 | 2023-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | DeferredTaxAssets | DeferredTaxAssets | CHF | 0 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | DefinedBenefitObligationAtPresentValue | DefinedBenefitObligationAtPresentValue | CHF | 7.61M | 2022-06-30 | 2022 | Q2 | 6-K/A | 2022-09-14 | 0001104659-22-099810 | |
| ifrs-full | DepreciationExpense | DepreciationExpense | CHF | 4,236 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | DepreciationPropertyPlantAndEquipment | DepreciationPropertyPlantAndEquipment | CHF | 212 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | DepreciationRightofuseAssets | DepreciationRightofuseAssets | CHF | 4,023 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | DerivativesPercentageContributedToFairValueOfPlanAssets | DerivativesPercentageContributedToFairValueOfPlanAssets | pure | 0.024 | 2023-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | DilutedEarningsLossPerShare | DilutedEarningsLossPerShare | CHF/shares | -0.03 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | DilutedEarningsLossPerShareFromContinuingOperations | DilutedEarningsLossPerShareFromContinuingOperations | CHF/shares | -0.03 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | DilutedEarningsLossPerShareFromDiscontinuedOperations | DilutedEarningsLossPerShareFromDiscontinuedOperations | CHF/shares | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | DisposalsRightofuseAssets | DisposalsRightofuseAssets | CHF | 7,408 | 2024-01-01 | 2024-12-31 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | EffectOfExchangeRateChangesOnCashAndCashEquivalents | EffectOfExchangeRateChangesOnCashAndCashEquivalents | CHF | -32,025 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | EmployeeBenefitsExpense | EmployeeBenefitsExpense | CHF | 145,538 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | Equity | Equity | CHF | 7.21M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | EquityAndLiabilities | EquityAndLiabilities | CHF | 8.51M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | EquityInstrumentsPercentageContributedToFairValueOfPlanAssets | EquityInstrumentsPercentageContributedToFairValueOfPlanAssets | pure | 0.14 | 2023-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | EstimatedFinancialEffectOfContingentLiabilities | EstimatedFinancialEffectOfContingentLiabilities | CHF | 0 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | EstimateOfContributionsExpectedToBePaidToPlan | EstimateOfContributionsExpectedToBePaidToPlan | CHF | 28,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 |
| ifrs-full | ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets | ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets | CHF | 44,098 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ExpenseFromSharebasedPaymentTransactionsWithEmployees | ExpenseFromSharebasedPaymentTransactionsWithEmployees | CHF | 4,287 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed | ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed | CHF | 1,545 | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | FinanceCosts | FinanceCosts | CHF | 13,322 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | FinanceIncome | FinanceIncome | CHF | 3 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | FinanceIncomeCost | FinanceIncomeCost | CHF | -13,319 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | GainsLossesOnChangesInEffectOfLimitingNetDefinedBenefitAssetToAssetCeilingExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans | GainsLossesOnChangesInEffectOfLimitingNetDefinedBenefitAssetToAssetCeilingExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans | CHF | 9,496 | 2023-01-01 | 2023-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 |
| ifrs-full | GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss | GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss | CHF | -11,945 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | GeneralAndAdministrativeExpense | GeneralAndAdministrativeExpense | CHF | 1.06M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | GrossLeaseLiabilities | GrossLeaseLiabilities | CHF | 47,739 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | IncomeTaxExpenseContinuingOperations | IncomeTaxExpenseContinuingOperations | CHF | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 |
| ifrs-full | IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges | IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges | CHF | -1.01M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | IncreaseDecreaseInNetDefinedBenefitLiabilityAsset | IncreaseDecreaseInNetDefinedBenefitLiabilityAsset | CHF | -100,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | IncreaseDecreaseThroughExerciseOfWarrantsEquity | IncreaseDecreaseThroughExerciseOfWarrantsEquity | CHF | 35,981 | 2023-01-01 | 2023-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 |
| ifrs-full | IncreaseDecreaseThroughSharebasedPaymentTransactions | IncreaseDecreaseThroughSharebasedPaymentTransactions | CHF | 44,098 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment | IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment | CHF | -18,987 | 2024-01-01 | 2024-12-31 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | IncreaseDecreaseThroughTransfersRightofuseAssets | IncreaseDecreaseThroughTransfersRightofuseAssets | CHF | -231,272 | 2024-01-01 | 2024-12-31 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities | IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities | CHF | 2,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 20-F | 2023-03-30 | 0001104659-23-038581 |
| ifrs-full | InsuranceExpense | InsuranceExpense | CHF | 91,857 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | InterestExpense | InterestExpense | CHF | 365 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | InterestExpenseDefinedBenefitPlans | InterestExpenseDefinedBenefitPlans | CHF | 10,799 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | InterestExpenseOnLeaseLiabilities | InterestExpenseOnLeaseLiabilities | CHF | 1,012 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | InterestIncomeDefinedBenefitPlans | InterestIncomeDefinedBenefitPlans | CHF | 9,721 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | InterestPaidClassifiedAsFinancingActivities | InterestPaidClassifiedAsFinancingActivities | CHF | 1,377 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | InvestmentsInAssociatesAccountedForUsingEquityMethod | InvestmentsInAssociatesAccountedForUsingEquityMethod | CHF | 5.01M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | IssuedCapital | IssuedCapital | CHF | 1.84M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | IssueOfEquity | IssueOfEquity | CHF | 4.28M | 2019-01-01 | 2019-12-31 | 2021 | FY | 20-F | 2022-03-10 | 0001104659-22-032171 |
| ifrs-full | KeyManagementPersonnelCompensation | KeyManagementPersonnelCompensation | CHF | 240,584 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | KeyManagementPersonnelCompensationSharebasedPayment | KeyManagementPersonnelCompensationSharebasedPayment | CHF | 43,428 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | LeaseLiabilities | LeaseLiabilities | CHF | 41,994 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | LiabilityAssetOfDefinedBenefitPlans | LiabilityAssetOfDefinedBenefitPlans | CHF | 111,947 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | LicenceFeeIncome | LicenceFeeIncome | CHF | 4.88M | 2018-01-01 | 2018-12-31 | 2020 | FY | 20-F | 2021-03-11 | 0001047469-21-000566 |
| ifrs-full | LongtermBorrowings | LongtermBorrowings | CHF | 0 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | LongtermDeposits | LongtermDeposits | CHF | 7,086 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | MiscellaneousOtherOperatingIncome | MiscellaneousOtherOperatingIncome | CHF | 1,870 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | NetDebt | NetDebt | CHF | -3.31M | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | NetForeignExchangeLoss | NetForeignExchangeLoss | CHF | 581,128 | 2020-01-01 | 2020-12-31 | 2020 | FY | 20-F | 2021-03-11 | 0001047469-21-000566 |
| ifrs-full | NoncurrentAssets | NoncurrentAssets | CHF | 5.85M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities | NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities | CHF | 89,232 | 2023-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | NoncurrentDerivativeFinancialAssets | NoncurrentDerivativeFinancialAssets | CHF | 509,067 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | NoncurrentFinancialAssets | NoncurrentFinancialAssets | CHF | 7,086 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome | NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome | CHF | 285,962 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | NoncurrentLeaseLiabilities | NoncurrentLeaseLiabilities | CHF | 30,896 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | NoncurrentLiabilities | NoncurrentLiabilities | CHF | 142,843 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | NoncurrentRecognisedLiabilitiesDefinedBenefitPlan | NoncurrentRecognisedLiabilitiesDefinedBenefitPlan | CHF | 111,947 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented | NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented | EquityInstruments | 63.25M | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-04-18 | 0001104659-24-048532 |
| ifrs-full | NumberOfSharesIssued | NumberOfSharesIssued | shares | 32.85M | 2020-12-31 | 2020 | FY | 20-F | 2021-03-11 | 0001047469-21-000566 | |
| ifrs-full | NumberOfSharesOutstanding | NumberOfSharesOutstanding | shares | 141.19M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | NumberOfSharesRepresentedByOneDepositaryReceipt | NumberOfSharesRepresentedByOneDepositaryReceipt | pure | 120 | 2023-10-23 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | OperatingExpense | OperatingExpense | CHF | 1.45M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | OtherAssetsPercentageContributedToFairValueOfPlanAssets | OtherAssetsPercentageContributedToFairValueOfPlanAssets | pure | 0.017 | 2021-12-31 | 2022 | FY | 20-F | 2023-03-30 | 0001104659-23-038581 | |
| ifrs-full | OtherComprehensiveIncome | OtherComprehensiveIncome | CHF | 53,219 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation | OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation | CHF | -1,088 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans | OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans | CHF | -202,389 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 |
| ifrs-full | OtherCurrentAssets | OtherCurrentAssets | CHF | 356,586 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | OtherCurrentFinancialAssets | OtherCurrentFinancialAssets | CHF | 6,994 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | OtherEquityInterest | OtherEquityInterest | CHF | 64.62M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | OtherExpenseByNature | OtherExpenseByNature | CHF | 380,109 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | OtherIncome | OtherIncome | CHF | 107,430 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | OtherReserves | OtherReserves | CHF | 31.23M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | ParValuePerShare | ParValuePerShare | CHF/shares | 0.01 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | PastServiceCostDefinedBenefitPlans | PastServiceCostDefinedBenefitPlans | CHF | -1,070 | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | PaymentsForShareIssueCosts | PaymentsForShareIssueCosts | CHF | 1.70M | 2021-01-01 | 2021-12-31 | 2023 | FY | 20-F | 2024-04-18 | 0001104659-24-048532 |
| ifrs-full | PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities | PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities | CHF | 3,607 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | PlanAssetsAtFairValue | PlanAssetsAtFairValue | CHF | 7.48M | 2022-06-30 | 2022 | Q2 | 6-K/A | 2022-09-14 | 0001104659-22-099810 | |
| ifrs-full | PostemploymentBenefitExpenseDefinedBenefitPlans | PostemploymentBenefitExpenseDefinedBenefitPlans | CHF | 16,121 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations | ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations | CHF | 57,673 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProceedsFromExerciseOfWarrants | ProceedsFromExerciseOfWarrants | CHF | 35,981 | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-04-18 | 0001104659-24-048532 |
| ifrs-full | ProceedsFromIssuingShares | ProceedsFromIssuingShares | CHF | 10.16M | 2021-01-01 | 2021-12-31 | 2023 | FY | 20-F | 2024-04-18 | 0001104659-24-048532 |
| ifrs-full | ProceedsFromSaleOrIssueOfTreasuryShares | ProceedsFromSaleOrIssueOfTreasuryShares | CHF | 777,546 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProfessionalFeesExpense | ProfessionalFeesExpense | CHF | 622,635 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProfitLoss | ProfitLoss | CHF | -3.31M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity | ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity | CHF | -3.31M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects | ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects | CHF | -3.31M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProfitLossBeforeTax | ProfitLossBeforeTax | CHF | -3.43M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProfitLossFromContinuingOperations | ProfitLossFromContinuingOperations | CHF | -3.43M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity | ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity | CHF | -3.43M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects | ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects | CHF | -3.43M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProfitLossFromDiscontinuedOperations | ProfitLossFromDiscontinuedOperations | CHF | 117,747 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity | ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity | CHF | 117,747 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects | ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects | CHF | 117,747 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ProfitLossFromOperatingActivities | ProfitLossFromOperatingActivities | CHF | -1.34M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | PropertyPlantAndEquipment | PropertyPlantAndEquipment | CHF | 919 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | PurchaseOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeClassifiedAsInvestingActivities | PurchaseOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeClassifiedAsInvestingActivities | CHF | 285,962 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities | PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities | CHF | 14,795 | 2019-01-01 | 2019-12-31 | 2020 | FY | 20-F | 2021-03-11 | 0001047469-21-000566 |
| ifrs-full | PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | CHF | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | RawMaterialsAndConsumablesUsed | RawMaterialsAndConsumablesUsed | CHF | 4,021 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | RealEstatePercentageContributedToFairValueOfPlanAssets | RealEstatePercentageContributedToFairValueOfPlanAssets | pure | 0.246 | 2023-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | ResearchAndDevelopmentExpense | ResearchAndDevelopmentExpense | CHF | 390,520 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | RetainedEarnings | RetainedEarnings | CHF | -356.68M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans | ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans | CHF | 21,832 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 |
| ifrs-full | ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset | ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset | CHF | -106,340 | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F | 2022-03-10 | 0001104659-22-032171 |
| ifrs-full | RevenueAndOperatingIncome | RevenueAndOperatingIncome | CHF | 107,430 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | RevenueFromContractsWithCustomers | RevenueFromContractsWithCustomers | CHF | 348,757 | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | RevenueFromInterest | RevenueFromInterest | CHF | 3 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | RightofuseAssets | RightofuseAssets | CHF | 37,555 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | SaleOrIssueOfTreasuryShares | SaleOrIssueOfTreasuryShares | CHF | 777,546 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ShareIssueRelatedCost | ShareIssueRelatedCost | CHF | 7,037 | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillNotBeReclassifiedToProfitOrLossNetOfTax | ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillNotBeReclassifiedToProfitOrLossNetOfTax | CHF | -164,101 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 |
| ifrs-full | ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod | ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod | CHF | -2.08M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | SharePremium | SharePremium | CHF | 266.94M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates | SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates | shares | 43.16M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | ShorttermDepositsClassifiedAsCashEquivalents | ShorttermDepositsClassifiedAsCashEquivalents | CHF | 4.65M | 2019-12-31 | 2020 | FY | 20-F | 2021-03-11 | 0001047469-21-000566 | |
| ifrs-full | SocialSecurityContributions | SocialSecurityContributions | CHF | 11,550 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | SurplusDeficitInPlan | SurplusDeficitInPlan | CHF | -164,251 | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss | TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss | CHF | 321,494 | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-04-18 | 0001104659-24-048532 |
| ifrs-full | TaxEffectOfForeignTaxRates | TaxEffectOfForeignTaxRates | CHF | -1,658 | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-04-18 | 0001104659-24-048532 |
| ifrs-full | TaxEffectOfTaxLosses | TaxEffectOfTaxLosses | CHF | 1.68M | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-04-18 | 0001104659-24-048532 |
| ifrs-full | TaxExpenseIncomeAtApplicableTaxRate | TaxExpenseIncomeAtApplicableTaxRate | CHF | -1.48M | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-04-18 | 0001104659-24-048532 |
| ifrs-full | TradeAndOtherCurrentPayables | TradeAndOtherCurrentPayables | CHF | 1.14M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | TradeAndOtherCurrentPayablesToTradeSuppliers | TradeAndOtherCurrentPayablesToTradeSuppliers | CHF | 640,087 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | TradeAndOtherCurrentReceivables | TradeAndOtherCurrentReceivables | CHF | 38,439 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | TreasuryShares | TreasuryShares | CHF | 738,489 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 | |
| ifrs-full | UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised | UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised | CHF | 175.50M | 2024-12-31 | 2024 | FY | 20-F | 2025-05-15 | 0001104659-25-049380 | |
| ifrs-full | WagesAndSalaries | WagesAndSalaries | CHF | 113,580 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |
| ifrs-full | WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 | WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 | pure | 0.047 | 2018-12-31 | 2019 | FY | 20-F | 2020-04-27 | 0001047469-20-002580 | |
| ifrs-full | WeightedAverageShares | WeightedAverageShares | shares | 99.44M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-30 | 0001104659-25-094663 |